Health-related quality of life in children with cancer undergoing treatment: A first look at the Singapore experience

Annals of the Academy of Medicine Singapore

Volumn 39, Issue 1, 2010, Pages 43-48

  Pek, Jen Heng ^a   Chan, Yiong Huak ^a   Yeoh, Allen E J ^a   Quah, Thuan Chong ^a   Tan, Poh Lin ^a   Aung, LeLe ^a  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

Childhood cancer; Self reported health and well being

Indexed keywords

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ANXIETY; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; FEMALE; GERM CELL TUMOR; HEMATOLOGIC MALIGNANCY; HUMAN; INTERPERSONAL COMMUNICATION; LYMPHATIC LEUKEMIA; MALE; NAUSEA; NEUROBLASTOMA; OSTEOSARCOMA; PAIN; PAIN ASSESSMENT; QUALITY OF LIFE; SCHOOL CHILD; SCORING SYSTEM; SELF REPORT; SINGAPORE; SOLID TUMOR;

EID: 75749096815     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Fayers PM, Machin D. Quality of Life: Assessment, Analysis, and Interpretation. New York: Wiley, 2000.
2. Spilker B. Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd ed. Philadelphia: Lippincott-Raven, 1996.
3. Varni JW, Seid M, Kurtin PS. Pediatric health-related quality of life measurement technology: A guide for health care decision makers. J Clin Outcomes Management 1999,6:33-40.
4. FDA. Guidance for Industry: Patient-reported outcome measures: Use in medical product development to support labeling claims. Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD, 2006.
5. World Health Organisation. Constitution of the World Health Organisation: Basic Document. Geneva, Switzerland: World Health Organisation, 1948.
6. Stiller CA, Eatock EM. Patterns of care and survival for children with acute lymphoblastic leukaemia diagnosed between 1980 and 1994. Arch Dis Child 1999;81:202-8.
7. Tan RM, Quah TC, Aung L, Liang S, Kirk RC, Yeoh AE. Improved outcome in childhood acute myeloid leukemia in Singapore with the MRC AML 10 protocol. Pediatr Blood Cancer 2007;48:262-7.
8. Dryer ZE, Blatt J, Bleyer A. Late effects of childhood cancer and its treatment. In: Pizzo PA, Poplack DG, editors. Principles and Practice of Pediatric Oncology. 4th ed. Philadelphia, Pa: Lippincott, Williams & Wilkins, 2002:1431-61.
9. Marina N. Long-term survivors of childhood cancer: the medical consequences of cure. Pediatr Clin North Am 1997;44:1021-42. addressed earlier by the healthcare team, the parents and many support facilities. Future plans include prospective multi-institutional studies assessing HRQOL at various time points during the treatment of childhood cancer in Singapore.
10. Eiser C. Practitioner review: long-term consequences of childhood cancer. J Child Psychol Psychiatry 1998;39:621-33.
11. AM Tan, Christina Ha. First Report of the Singapore Childhood Cancer Registry 1997-2005. Singapore: Singapore Childhood Cancer Registry.
12. Varni JW, Seid M, Rode CA. The PedsQL: Measurement model for the pediatric quality of life inventory. Med Care 1999;37:126-39.
13. Varni JW, Seid M, Kurtin PS. The PedsQL 4.0: Reliability and validity of the pediatric quality of life inventory, version 4.0 generic core scales in healthy and patient populations. Med Care 2001;3:800-12.
14. Varni JW, Katz ER, Seid M, Quiggins DJ, Friedman-Bender A, Castro CM. The Pediatric Cancer Quality of Life Inventory (PCQL). I. Instrument development, descriptive statistics, and cross-informant variance. J Behav Med 1998;21:179-204.
15. Davies HA. Late problems faced by childhood cancer survivors. Br J Hosp Med 1993;50:137-40.
16. Zevon MA, Neubauer NA, Green DM. Adjustment and vocational satisfaction of patients treated during childhood or adolescence for acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol 1990;12:454-61.
17. Gray RE, Doan BD, Shermer P, FitzGerald AV, Berry MP, Jenkin D, et al. Psychologic adaptation of survivors of childhood cancer. Cancer 1992;70:2713-21.
18. Pui CH, Cheng C, Leung W, Rai SN, Rivera GK, Sandlund JT, et al. Extended follow-up of long-term survivors of childhood acute lymphoblastic leukemia. N Engl J Med 2003;349:640-9.
19. Hinds PS, Hockenberry MJ, Gattuso JS, Srivastava DK, Tong X, Jones H, et al. Dexamethasone alters sleep and fatigue in pediatric patients with acute lymphoblastic leukemia. Cancer 2007;110:2321-30.
20. Buizer AI, de Sonneville LM, van den Heuvel-Eibrink MM, Veerman AJ. Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: effect of treatment intensity. Pediatr Blood Cancer 2005;45:281-90.
21. Creutzig U, Zimmermann M, Reinhardt D, Dworzak M, Stary J, Lehrnbecher T. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: Analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol 2004;22:4384-93.
22. Creutzig U, Körholz D, Niemeyer CM, Kabisch K, Graf N, Reiter A, et al. 3 × 14 mg idarubicin during induction: results of a pilot study in children with AML. Leukemia 2000;14:340-2.
23. Grimer RJ, Taminiau AM, Cannon SR. Surgical outcomes in osteosarcoma. J Bone Joint Surg Br 2002;84:395.
24. Nagarajan R, Neglia JP, Clohisy DR, Robison LL. Limb salvage and amputation in survivors of pediatric lower-extremity bone tumors: what are the long-term implications? J Clin Oncol 2002;20:4493.